164 related articles for article (PubMed ID: 9392507)
1. Thiazolidinediones downregulate stearoyl-CoA desaturase 1 gene expression in 3T3-L1 adipocytes.
Kurebayashi S; Hirose T; Miyashita Y; Kasayama S; Kishimoto T
Diabetes; 1997 Dec; 46(12):2115-8. PubMed ID: 9392507
[TBL] [Abstract][Full Text] [Related]
2. Differential regulation of the stearoyl-CoA desaturase genes by thiazolidinediones in 3T3-L1 adipocytes.
Kim YC; Gomez FE; Fox BG; Ntambi JM
J Lipid Res; 2000 Aug; 41(8):1310-6. PubMed ID: 10946019
[TBL] [Abstract][Full Text] [Related]
3. Regulation of stearoyl-CoA desaturase 1 mRNA stability by polyunsaturated fatty acids in 3T3-L1 adipocytes.
Sessler AM; Kaur N; Palta JP; Ntambi JM
J Biol Chem; 1996 Nov; 271(47):29854-8. PubMed ID: 8939925
[TBL] [Abstract][Full Text] [Related]
4. Concentration-dependent stimulatory and inhibitory effect of troglitazone on insulin-induced fatty acid synthase expression and protein kinase B activity in 3T3-L1 adipocytes.
Barthel A; Krüger KD; Roth RA; Joost HG
Naunyn Schmiedebergs Arch Pharmacol; 2002 Apr; 365(4):290-5. PubMed ID: 11919653
[TBL] [Abstract][Full Text] [Related]
5. The trans-10,cis-12 isomer of conjugated linoleic acid downregulates stearoyl-CoA desaturase 1 gene expression in 3T3-L1 adipocytes.
Choi Y; Kim YC; Han YB; Park Y; Pariza MW; Ntambi JM
J Nutr; 2000 Aug; 130(8):1920-4. PubMed ID: 10917902
[TBL] [Abstract][Full Text] [Related]
6. The transcription factor Fos-related antigen 1 is induced by thiazolidinediones during differentiation of 3T3-L1 cells.
Albrektsen T; Fleckner J
Mol Pharmacol; 2001 Mar; 59(3):567-75. PubMed ID: 11179452
[TBL] [Abstract][Full Text] [Related]
7. Stearoyl-coenzyme A desaturase 1 gene expression increases after pioglitazone treatment and is associated with peroxisomal proliferator-activated receptor-gamma responsiveness.
Yao-Borengasser A; Rassouli N; Varma V; Bodles AM; Rasouli N; Unal R; Phanavanh B; Ranganathan G; McGehee RE; Kern PA
J Clin Endocrinol Metab; 2008 Nov; 93(11):4431-9. PubMed ID: 18697866
[TBL] [Abstract][Full Text] [Related]
8. Troglitazone downregulates delta-6 desaturase gene expression in human skeletal muscle cell cultures.
Wahl HG; Kausch C; Machicao F; Rett K; Stumvoll M; Häring HU
Diabetes; 2002 Apr; 51(4):1060-5. PubMed ID: 11916926
[TBL] [Abstract][Full Text] [Related]
9. Effects of sterculic acid on stearoyl-CoA desaturase in differentiating 3T3-L1 adipocytes.
Gomez FE; Bauman DE; Ntambi JM; Fox BG
Biochem Biophys Res Commun; 2003 Jan; 300(2):316-26. PubMed ID: 12504086
[TBL] [Abstract][Full Text] [Related]
10. Regulation of stearoyl-CoA desaturase genes: role in cellular metabolism and preadipocyte differentiation.
Kim YC; Ntambi JM
Biochem Biophys Res Commun; 1999 Dec; 266(1):1-4. PubMed ID: 10581155
[TBL] [Abstract][Full Text] [Related]
11. Stearoyl-CoA desaturase 2 is required for peroxisome proliferator-activated receptor gamma expression and adipogenesis in cultured 3T3-L1 cells.
Christianson JL; Nicoloro S; Straubhaar J; Czech MP
J Biol Chem; 2008 Feb; 283(5):2906-16. PubMed ID: 18032385
[TBL] [Abstract][Full Text] [Related]
12. Troglitazone inhibits the expression of inducible nitric oxide synthase in adipocytes in vitro and in vivo study in 3T3-L1 cells and Otsuka Long-Evans Tokushima Fatty rats.
Dobashi K; Asayama K; Nakane T; Kodera K; Hayashibe H; Nakazawa S
Life Sci; 2000 Sep; 67(17):2093-101. PubMed ID: 11057759
[TBL] [Abstract][Full Text] [Related]
13. Differential effects among thiazolidinediones on the transcription of thromboxane receptor and angiotensin II type 1 receptor genes.
Sugawara A; Takeuchi K; Uruno A; Ikeda Y; Arima S; Sato K; Kudo M; Taniyama Y; Ito S
Hypertens Res; 2001 May; 24(3):229-33. PubMed ID: 11409645
[TBL] [Abstract][Full Text] [Related]
14. A novel method for analysis of nuclear receptor function at natural promoters: peroxisome proliferator-activated receptor gamma agonist actions on aP2 gene expression detected using branched DNA messenger RNA quantitation.
Burris TP; Pelton PD; Zhou L; Osborne MC; Cryan E; Demarest KT
Mol Endocrinol; 1999 Mar; 13(3):410-7. PubMed ID: 10076998
[TBL] [Abstract][Full Text] [Related]
15. Troglitazone treatment increases plasma vascular endothelial growth factor in diabetic patients and its mRNA in 3T3-L1 adipocytes.
Emoto M; Anno T; Sato Y; Tanabe K; Okuya S; Tanizawa Y; Matsutani A; Oka Y
Diabetes; 2001 May; 50(5):1166-70. PubMed ID: 11334422
[TBL] [Abstract][Full Text] [Related]
16. Effect of troglitazone on plasma lipid metabolism and lipoprotein lipase.
Kobayashi J; Nagashima I; Hikita M; Bujo H; Takahashi K; Otabe M; Morisaki N; Saito Y
Br J Clin Pharmacol; 1999 Apr; 47(4):433-9. PubMed ID: 10233209
[TBL] [Abstract][Full Text] [Related]
17. Thiazolidinediones inhibit lipoprotein lipase activity in adipocytes.
Ranganathan S; Kern PA
J Biol Chem; 1998 Oct; 273(40):26117-22. PubMed ID: 9748292
[TBL] [Abstract][Full Text] [Related]
18. Troglitazone, an antidiabetic agent, inhibits cholesterol biosynthesis through a mechanism independent of peroxisome proliferator-activated receptor-gamma.
Wang M; Wise SC; Leff T; Su TZ
Diabetes; 1999 Feb; 48(2):254-60. PubMed ID: 10334298
[TBL] [Abstract][Full Text] [Related]
19. Increased adipose expression of the uncoupling protein-3 gene by thiazolidinediones in Wistar fatty rats and in cultured adipocytes.
Matsuda J; Hosoda K; Itoh H; Son C; Doi K; Hanaoka I; Inoue G; Nishimura H; Yoshimasa Y; Yamori Y; Odaka H; Nakao K
Diabetes; 1998 Nov; 47(11):1809-14. PubMed ID: 9792555
[TBL] [Abstract][Full Text] [Related]
20. Thiazolidinediones inhibit the expression of beta3-adrenergic receptors at a transcriptional level.
Bakopanos E; Silva JE
Diabetes; 2000 Dec; 49(12):2108-15. PubMed ID: 11118014
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
